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Abstract The eye lens proteins of the mouse were separated
into 1940 polypeptide spots by two-dimensional electrophoresis in
large gels. All 16 crystallins ubiquitous in mammals were
identified by protein sequencing and mass spectrometry except
for (Q)-F, which shows an almost identical sequence with (Q)-E.
Two crystallins, (L)-A2 and (Q)-S, were shown for the first time
to occur in the mouse lens. An investigation of the murine
cataract mutant Cat2nop ((Q)-B gene) demonstrated that a
monogenic mutation might affect a broad spectrum of proteins.
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1. Introduction
The eye lens can be regarded as a protein container organ-
ized in many concentric protein layers, which develop con-
stantly from embryonic stage E11 throughout life [1]. The
vast majority of these proteins, i.e. 80^90%, belong to one
particular protein family, the crystallins. The sequence, struc-
ture and quantity of the individual crystallins determine the
intermolecular interactions of these proteins and consequently
the supramolecular organization of the lens. The short-range,
glass-like order of the crystallins accounts for eye lens trans-
parency [2]. Phase changes in the supramolecular structure of
the lens can lead to opacity. Therefore, mutations in crystallin
genes a¡ecting the structure or amount of a certain crystallin
or its spatial or temporal occurrence can result in eye lens
defects such as cataracts.
In the mouse about 170 independent cataract mutations
have been induced chemically or by radiation and character-
ized phenotypically ([3,4] ; Favor, unpublished). Mouse lines
were raised from these mutants and used for allelism studies
[5], gene mapping and sequencing [6^9] and investigations on
gene expression [10^12] in order to characterize mutations
responsible for cataract development. To understand the eti-
ology and pathogenesis of genetic lens defects the detection
and identi¢cation of the individual crystallins (and other lens
proteins) including information on their post-translational
modi¢cations, their relative amounts and changes during de-
velopment and aging are essential.
The crystallins occurring in all mammalian species were
classi¢ed into crystallin (K)-A and (K)-B, (L)-A1 through
(L)-A4 and (L)-B1 through (L)-B3, (Q)-A through (Q)-F and
(Q)-S. In addition, several taxon-speci¢c crystallins are known
[1]. All common human crystallins have been sequenced and
identi¢ed in two-dimensional (2D) electrophoresis patterns
[13^17]; the (L)-A2, (Q)-E and F, however, do not occur in
the human lens [17]. In mouse and rat the crystallin family has
not been analyzed completely. 2D electrophoresis patterns of
mouse lens proteins were used for detecting changes in the
level of di¡erent crystallins in CatFraser mouse mutants
[18], in buthionine sulfoximine treated mice [19], and in trans-
genic mice [20].
In the investigation presented here we resolved the total lens
proteins of the mouse by large gel 2D electrophoresis, a high
performance 2D technique leading to maximum resolution
[21]. In the resulting protein pattern we identi¢ed by Edman
degradation and mass spectrometry (MS) all the common
crystallins except (Q)-F, which shows more than 95% sequence
similarity to crystallin (Q)-E. By analyzing the murine cataract
mutant Nop, we demonstrate that highly resolved, well-stand-
ardized and informative 2D electrophoresis patterns of mouse
lens proteins can be used to study the e¡ect of gene mutations
on individual crystallins.
2. Materials and methods
2.1. Mouse strains
The mice investigated were from the Institut fuºr Saºugetiergenetik,
GSF-Forschungszentrum Neuherberg and originated from mouse
strains used in this institute for detecting induced mutations by
the speci¢c locus test [22]. Normal eye lenses were taken from
(102/ElUC3H/El) F1 mice (¢ve females, ¢ve males, 33^51 weeks
old), cataract mutants (two males, 42 weeks) from strain 359 bearing
the mutation Nop (allele symbol Cat2nop). Mutation 359 is of sponta-
neous origin [10] and has been shown to be a frameshift mutation
(Crygbnop) of the Crygb gene, the gene of the (Q)-B crystallin [9].
2.2. Extraction of lens proteins
Mouse lenses were dissected from the eyes leaving the lens capsule
intact. The two lenses of an individual were rinsed with physiological
saline, freed from any adjacent £uid, weighed and frozen immediately
in liquid nitrogen. A mortar and pestle were pre-cooled in liquid
nitrogen. The following components were added to the mortar and
were ground down to a ¢ne powder: a pair of lenses (a mg; e.g.
13.7 mg), bu¡er (a mgU8 = b Wl), protease inhibitor 1 ([a mg +
b Wl]U0.08 = c Wl), protease inhibitor 2 ([a mg + b Wl]U0.02 = d Wl).
Bu¡er: phosphate bu¡er pH 7.1 containing 0.2 M KCl, 5.1% CHAPS
(= 4.5% in the ¢nal homogenate), 20% glycerol. Inhibitor 1: one cock-
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tail tablet Complete (Boehringer Mannheim, Mannheim, Germany)
dissolved in 2 ml bu¡er. Inhibitor 2: a mixture of one part pepstatin
A (9.6 mg in 100 ml ethanol, dissolved at 37‡C) and one part phenyl-
methylsulfonyl £uoride (1.742 g in 100 ml ethanol). The powder was
transferred into a 1.5 ml Eppendorf tube, then thawed and sonicated
in an ice cold water bath, six times for 10 s with intervals of 110 s.
Glass beads, 2.2^2.5 mm in diameter, were added to the homogenate
for sonication ([a mg+b Wl+c Wl+d Wl]U0.034 = number of glass
beads). After sonication and removal of the beads, the homogenate
was weighed (e mg) and stirred for 30 min in the cold room. The
homogenate was mixed with urea (e mgU1.08) and 1.54 M DTT
(e mgU0.1), stirred for 45 min at room temperature, and then mixed
with ampholytes (Servalyte) pH 2^4 (e mgU0.1). The ¢nal concen-
trations of the additives were 9 M urea, 70 mM DTT, 2% ampholytes.
The resulting sample was stored in aliquots at 370‡C and diluted with
1 part diluent (9 M urea, 70 mM DTT, 2% Servalyte pH 2^4 in
bidistilled water) before analysis. For 2D electrophoresis 4 Wl of the
sample was applied to a 44.5 cm IEF tube gel. Note that the proce-
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Table 1
Mouse crystallins identi¢ed in 2D electrophoresis patterns of eye lens proteins by Edman degradation, PSD-MALDI-MS and peptide mass
¢ngerprinting
Crystallins ubiquitous in
mammalian eye lens
Analysis of proteins from 2D gels Matching protein species from database
Spot No. Sequence of peptidea Peptide mass Species Identi¢cation No.b Residue No.
(K)-A 25 QSLFR mouse CRAA_RAT (SP) 50^54
TVLDSGISEVRc 55^65
(K)-A 182 ALGPFYPSR 1007 mouse CRAA_RAT (SP) 13^21
CRA2_MOUSE (SP)
(K)-B 176 APSWIDTGL mouse CRAB_MOUSE (SP) 57^65
FSVNLDV 75^81
VLGDVIEVH 93^101
IPADVDPL 124^131
EEKPAVAAAPc 164^173
(L)-A1 280 ITIYDQENFQGK mouse CRBA_MOUSE (SP) 16^27
NFDNVR 42^47
ITNFEK 109^114
(L)-A1 29 ITIFDQENFQG mouse CRBA_MOUSE (SP) 16^26
NFDNV 42^46
GEYP 74^77
SYLSR ^
(L)-A2 158 TYSDFGTQAHTGQLQSIR 2010 bovine CRBB_BOVIN (SP) 175^192
(L)-A3 423 ELETLPTTKc human CRBA_HUMAN (SP) 9^17
(L)-A4 35 MVVWDEEGFQGY bovine CRBD_BOVIN (SP) 27^38
(L)-B1 57 GEMFVLEc 1036 (Mox) rat CRB1_RAT (SP) 107^113
(L)-B2 115 WDSWTSSRc 1024 mouse CRB2_MOUSE (SP) 81^88
TDSLSSLRPIKc 1216 90^99
1409 108^119
2076 48^67
(L)-B3 167 QYVFERc rat CRB3_RAT (SP) 170^175
VINGTWVGYEFPGYRc 153^167
(L)-B3 226 VASIR rat CRB3_RAT (SP) 148^152
QYVFERc 170^175
VINGTXVGYc 153^165
GEQFVLEKc 76^83
(Q)-A 247 ITFYEDR 944 mouse CRGA_MOUSE (SP) 3^9
GFQGR 10^14
GDYPDYQQWMGFX 60^71
QYLLRPGDYRc 1281 142^151
1049 80^88
2113 (Wox,
Mox)
60^76
2788 37^58
(Q)-B 223 ITFFED mouse S33523 (PIR) 4^9
VDSGCWML 38^45
GEYPDYQQXMGFSDS 61^75
GQMSEITDc 101^108
YLDWGAANAKc 155^164
(Q)-B 224 ITFFEDR mouse S33523 (PIR) 4^10
LIPQHSGTYR 1171 81^90
YLDWGAANAKc 1112 155^164
DDFR (kynurenine) 97^100
(Q)-C 239 IXFFEDR 928 mouse S33526 (PIR) 4^10
QYLLRPQEYR 1365 CRGC_MOUSE (SP) 143^152
FQDWGSVDAK 1184 (Wox) 154^163
VVDLY ^ 170^174
2125 61^77
2281 60^77
FQDWGSVDAKc 1155 154^163
(kynurenine)
(continued on next page)
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dure described did not include a centrifugation step. A more detailed
description of our highly standardized sample preparation procedure
for 2D electrophoresis is given elsewhere [23].
2.3. 2D electrophoresis and image analysis
Two-dimensional electrophoresis was performed using the large gel
technique described by Klose and Kobalz [21,24]. For separating lens
proteins the ampholyte mixture was altered to spread the crystallin
spots more in the horizontal direction (i.e. according to charge). The
mixture consisted of one part Pharmalyte pH 3.5^10 and three parts
Pharmalyte pH 5^8. From each of the 10 normal animals included in
this investigation, a 2D pattern of total lens proteins was produced.
One of these patterns was scanned with a laser scanner (type MD
300A, Molecular Dynamics, Krefeld, Germany), digitalized using a
VAX station and transferred into a graphic spot pattern employing
the spot detection program developed by Prehm et al. [25]. The pat-
tern revealed by image analysis was corrected interactively on the
terminal screen by comparison with the original gel pattern. The re-
sulting pattern was checked visually against each of the nine other 2D
patterns to ensure that each spot (except tiny spots at the detection
limit) of the primary standard pattern was representative of mouse eye
lens proteins. The ¢nal standard pattern was saved in the computer as
a reference pattern for any information obtained for individual spots
in further investigations.
2.4. Blotting
The proteins from 2D gels were blotted onto PVDF membranes as
described [26] and stained with sulforhodamine [27]. For this purpose
2D electrophoresis was performed as indicated above with the excep-
tion that the sample was not diluted with one part diluent and 5 Wl of
the sample was applied to the IEF gel instead of 4 Wl. Spots were cut
from the membrane and collected from three runs. This gave sample
material for the analytical studies.
2.5. Tryptic digestion and HPLC
Three cut spots per protein were incubated in 10^30 Wl of 50 mM
Tris-HCl, pH 7.8, 1 mM CaCl2, 10% v/v acetonitrile, 1% w/v octyl-L-
D-glucopyranoside and 0.2^0.5 Wg modi¢ed trypsin (Promega, Madi-
son, WI, USA) for 15 h at 37‡C. After incubation the extract was
transferred to a 0.5 ml Eppendorf vial and the membrane pieces were
washed ¢rst with 20^50 Wl of 0.1% v/v tri£uoroacetic acid (TFA) and
then with 20^50 Wl of 60% v/v acetonitrile/0.1% v/v TFA. Washing
was supported by sonication. The membrane pieces were collected at
the bottom of the tube by centrifugation. All supernatants were com-
bined with the primary extract. After speed vac concentration 10% of
the sample was used for peptide mass mapping and 90% was applied
to micro-HPLC (Smart system, Pharmacia, Freiburg, Germany) in
0.1% v/v TFA at a £ow rate of 100 Wl/min. The peptides were eluted
in a gradient of increasing acetonitrile concentrations, for more details
see [28]. The peptide containing fractions were used for Edman deg-
radation and MS.
2.6. Protein sequencing and MALDI-MS
Edman degradation of eluted peptides was performed in a Procise
sequencer (Perkin Elmer, Weiterstadt, Germany). Peptide mass ¢nger-
printing was performed in a time-of-£ight VG TOF Spec (Fisons,
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Table 1 (continued)
Crystallins ubiquitous in
mammalian eye lens
Analysis of proteins from 2D gels Matching protein species from database
Spot No. Sequence of peptidea Peptide mass Species Identi¢cation No.b Residue No.
(Q)-D 224 QYLLRPGEYR CYMSG1 (PIR) 143^152
GDYPDY 61^66
GFQGR 11^15
S/PGEY 148^151
VGSLR 164^168
ITFYEDR 942 4^10
1349c 153^163
1396 (Wox,
Mox)c
153^163
1835c 100^115
846 (Mox) 169^174
1193c 154^163
1256c 81^91
(Q)-E 246 ITFYEDR 942 mouse CYMSG2 (PIR) 4^10
GFQGR 564 JS0596 (PIR) 11^15
QYLLRPGEY 1295 S26811 (PIR) 143^152
YHDWGAMNARc 1219 154^163
2098 61^77
(Q)-E 224 QYLLRPGEYR 1295 mouse CYMSG2 (PIR) 143^152
GDYPDY JS0596 (PIR) 61^66
GFQGR S26811 (PIR) 11^15
S/PGEY 148^151
VGSLR 164^168
ITFYEDR 942 4^10
IYERc 580 92^95
2098 (Wox,
Mox)
61^77
(Q)-E 232 ITFYEDR 942 mouse CYMSG2 (PIR) 4^10
GDYPDYQQWMGF JS0596 (PIR) 61^72
IMDFYc S26811 (PIR) 170^174
1295 143^152
(Q)-Fd
(Q)-S 258 ISFYEDR 929 bovine CRBS_BOVIN (SP) 7^13
QYLL 148^151
NFQGRc 14^18
VSEGTXIFYELPNY 1888 131^144
aAmino acids written in bold type are not in agreement with the sequence database.
bSP: SwissProt; PIR: Protein Identi¢cation Resource.
cDiscriminative peptide.
dSee text.
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Manchester, UK). For mass determination by MALDI-MS and post-
source decay (PSD) sequencing the mass spectrometer Voyager Elite
(PerSeptive, Framingham, MA, USA) with delayed extraction and
re£ection was employed. A saturated solution of K-cyano-4-hydrox-
ycinnamic acid in aqueous 50% acetonitrile and 0.1% v/v TFA was
used as the matrix. Matrix and sample were mixed on the target (1:1
v/v).
3. Results
A 2D electrophoresis pattern of total proteins from a pair
of normal mouse eye lenses is shown in Fig. 1. The 10 pat-
terns compared from individual animals for constructing the
standard pattern were found to be almost identical with re-
gard to the relative position and intensity of the spots. The
high reproducibility may in part result from the fact that the
lens itself is a very reproducible organ. It is almost free of
foreign tissue, shows reduced metabolic activity and contains
well soluble proteins. Patterns from di¡erent fractions of lens
proteins, i.e. from the water-soluble and urea-soluble fractions
[23], did not reveal fraction-speci¢c protein spots or spots not
detectable in the total lens extract as used here (results not
shown). Furthermore, changes in the protein patterns, which
may be due to variations in age (33^51 weeks) or sex, were not
observed in the set of mice investigated. The resulting stand-
ard pattern of total mouse lens proteins revealed 1940 spots.
In the section pH 6.0^7.5/20^24 kDa a number of highly
abundant protein spots occurred (Fig. 2), most likely the crys-
tallins. Out of these, 19 spots were selected for partial amino
acid sequencing and peptide mass determination. The data
obtained were used to screen the SwissProt, PIR and NCBI
GenBank databases for sequence or mass matches.
Peptide mass ¢ngerprinting from on-blot digests by MAL-
DI-MS without delayed extraction was, in most cases, not
useful for identifying crystallins down to the level of individ-
ual species. Discrimination between highly similar crystallin
species was successful only when the distinguishing peptide
was sequenced by Edman degradation or PSD-MALDI-MS.
Mostly, this a¡orded sequencing of several peptides to ¢nd a
discriminative peptide. For example, to elucidate the three
protein species (Q)-B, D and E, within spot No. 224, 11 pep-
tides had to be sequenced.
The spots identi¢ed in the lens protein pattern are shown in
Fig. 2 and listed in Table 1. Out of the 16 di¡erent crystallins
known to occur ubiquitously in mammalian eye lenses, 14
were identi¢ed within the 19 analyzed spots by peptide mass
¢ngerprinting, Edman degradation or PSD sequencing. The
one missing crystallin, (Q)-F, has a high sequence similarity
with (Q)-E. Mouse (Q)-F (NCBI ID g56720) di¡ers from
(Q)-E (PIR ID JS0596) in ¢ve amino acids: G-S, G-A, T-A,
S-T, K-R. These exchanges should not result in a pI shift.
According to others [29], (Q)-F is identical with (Q)-E. Interest-
ingly, we found three spots for (Q)-E.
Both (Q)-B spot 224 and (Q)-C spot 239 contained a modi-
¢ed tryptophan at two di¡erent positions. In both cases tryp-
tophan was oxidized to kynurenine, which was clearly detect-
able by a mass shift of +4 in the respective peptide. Spots 223
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Fig. 1. Total eye lens proteins of the mouse separated by large gel 2D electrophoresis. Indicated section: see Fig. 2. Arrow: Crystallin (K)-A
(spot 25 in Table 1).
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and 224 belong to PIR S33523. Two spots were detected for
each of the following crystallins : (K)-A (No. 182 and arrow in
Fig. 1), (L)-A1 (Nos. 29 and 280) and (L)-B3 (Nos. 167 and
226). To identify a protein at the protein species level it is
imperative that each peptide determined matches for 100%
with the corresponding mouse protein of the sequence data-
base. This was not the case for spot 29, where most of the
amino acids matched with (L)-A1 except one amino acid and
one peptide containing ¢ve amino acids. Apparently, this pro-
tein is a subform of (L)-A1 not described in the sequence
database. Other non-¢tting amino acids occurred in our data-
base search only in assignments of crystallins to di¡erent or-
ganisms as indicated by bold letters in Table 1. One spot, 224,
contained peptides of three crystallins, (Q)-B, D and E. All
other protein spots identi¢ed revealed only one crystallin spe-
cies. In two cases di¡erentiation between very similar subspe-
cies was not possible: the single sequence obtained for spot
182 ((K)-A) did not allow us to discriminate between
CRAA_RAT, a protein species common to mouse and rat,
and CRA2_MOUSE, and the sequences detected for (Q)-E
were common to three subspecies in the database, CYSMSG2,
JS0596, and S26811. Only one spot and without any contam-
ination by other crystallins was detected for (K)-B, (L)-A2^4,
(L)-B1, (L)-B2, (Q)-A and (Q)-S.
For the crystallins (L)-A2^4, (L)-B1 and 3 and (Q)-S se-
quence data available in databases were from mammalian
species other than the mouse. Here, we used the rat for com-
parison, as far as possible, otherwise human and bovine. Gen-
erally, crystallins of the same type di¡er between these species
less than di¡erent types of crystallins within a species. For
example, the percentages sequence similarity for mouse crys-
tallins (Q)-A, (Q)-E, (Q)-B, (L)-B2, (L)-A1 relative to (Q)-A
FEBS 20815 18-9-98
Fig. 2. Section of the mouse eye lens protein pattern shown in Fig. 1 in combination with a computer pattern obtained by image analysis of
this section. The protein spots identi¢ed so far are indicated. In contrast to the pattern shown in Fig. 1, the proteins were stained just brie£y
in order to reveal the major spots more distinctly. Consequently, the (Q)-crystallins, which under this conditions stain yellow, occur faintly in
the photograph (for full staining see Fig. 3a).
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(CRGA_MOUSE) were 100%, 79.4%, 60.8%, 32.1%, 24.6%,
respectively. The percentages sequence similarity of mouse
against rat, human and bovine for (Q)-A (CRGA_MOUSE)
were 97.3%, 85.4%, 69.5%, respectively. The amino acid se-
quences of rat, human and bovine (L)-A4, as another exam-
ple, share 92^94% sequence similarity [16] and therefore, all
three mammalian species were helpful in identifying (L)-A4 in
the mouse. We identi¢ed most of the crystallins on the basis
of speci¢c sequences (Table 1).
Considering the position of the identi¢ed protein spots in
the 2D pattern (Fig. 2) it is obvious that the various (Q)-crys-
tallins are situated closely together in one region, except for
(Q)-S. The (Q)-D/E spot overlaps largely with one (Q)-B spot
(Fig. 3a). However, when using our ampholyte standard mix-
ture [21], these overlapping spots split into two spots (Fig. 3c)
and were blotted under these conditions for sequencing. The
(Q)-crystallin spots (except (Q)-S) were distinct from all other
spots by developing a yellow color in our silver staining pro-
cedure [21]. A few other yellow spots were observed in this
region apparently representing a set of minor spots split from
the major set of (Q)-crystallins (Fig. 3a,c). The (L)-A crystallins
and the (L)-B crystallins also form groups of spots in our 2D
pattern (Fig. 2), but very loosely.
In protein patterns of the cataract mutant Nop the intensity
(amount) of the whole (Q)-crystallin spot complex, with the
exception of (Q)-S, was drastically reduced (Fig. 3). (Q)-E
(the most basic spot in Fig. 3a), rather than the mutant
(Q)-B crystallin, was preferentially reduced. Quantitative
changes, i.e. decreased or increased intensities, were also ob-
served for a number of other spots, including crystallin spots,
but the reduction of the (Q)-crystallin spots was the most strik-
ing ¢nding made in the lens protein patterns of these mouse
mutants. Preliminary results from an investigation of six other
mouse cataract mutants also showed quantitative changes for
many spots of the lens protein pattern. These changes were
reproducible and, on the whole, characteristic for each cata-
ract mutant line.
4. Discussion
In this investigation we presented a 2D electrophoresis pat-
tern of total mouse eye lens proteins revealed under condi-
tions for maximum resolution. By densitometry and com-
puter-assisted image analysis 1940 protein spots were
detected. By protein sequencing and mass spectrometry all
16 crystallins ubiquitous in mammals were identi¢ed as sepa-
rate spots, with the exception of (Q)-F, which shows an iden-
tical or an almost identical sequence to (Q)-E; (Q)-D was mixed
with B and E. Two crystallins, (L)-A2 and (Q)-S, were shown
for the ¢rst time to occur in the mouse lens, (L)-A2, (L)-B1
and 3, and (Q)-A, B, D, E were demonstrated for the ¢rst time
in an electrophoretic 2D pattern.
Identi¢cation of protein species within a protein family af-
fords more sequence information than assignment of a protein
spot to a protein family, which has been the identi¢cation aim
for the annotation of most of the 2D protein databases col-
lected in the federated world 2D protein database (URL:
http://expasy.hcuge.ch/ch2d/2d-index.html) [30]. Here we
have shown the successful identi¢cation and discrimination
of all known members of a protein family revealed in a 2D
gel.
The spontaneous dominant cataract mutant Nop of the
mouse was detected by Graw et al. [9] and described as nu-
clear opacity of the lens. Recently the Nop mutation was
found in the (Q)-B crystallin gene [9]. Isoelectric focusing of
water-soluble lens proteins from Nop mice showed a reduced
content of (Q)-crystallin [10,11], a ¢nding supported by North-
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Fig. 3. The (Q)-crystallin region of 2D patterns from mouse lens
proteins. a: Normal mouse. The (Q)-crystallins (A, B, D, and E) are
fully expressed; a set of minor spots occurs (*) which re£ect the
composition and the red-brown color of the (Q)-crystallin spots.
b: Mouse cataract mutant Nop. The (Q)-crystallin spots are drasti-
cally reduced in size and intensity, (Q)-A and the set of minor spots
(see * in panel a) disappeared completely. Note that other spots
also show quantitative changes compared to the normal pattern.
c: Normal mouse. The proteins were run under di¡erent conditions
(altered composition of the ampholyte mixture, brief staining) for
better separation of (Q)-B from (Q)-D/E crystallins.
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ern blot results [12]. The (Q)-crystallins, however, result from
six individual genes organized as a cluster. Although only one
gene was a¡ected in the Nop mutant, our 2D analysis of the
Nop lens proteins showed that each of the six (Q)-crystallins
was heavily reduced in quantity, (Q)-E (the most basic spot)
more than the other ones; (Q)-S, a more distantly related (Q)-
crystallin, was not altered. In the heterozygote protein pattern
(Fig. 3b), the (Q)-B isoforms detected in the wild-type pattern
were present, but a candidate spot for the Cat2nop allele, i.e.
for a (Q)-B crystallin truncated by the loss of 32 amino acids
[9], was not observed. Quantitative changes in protein spots
other than those identi¢ed as (Q)-crystallins were found.
The analysis of the mouse Nop mutation by 2D electropho-
resis demonstrated that monogenic mutations may have plei-
otropic e¡ects involving a broad spectrum of proteins. Histo-
logical investigations of Nop lenses have shown that lens ¢ber
cell di¡erentiation was impaired (impaired elongation of the
¢ber cells, prolonged presence of ¢ber cell nuclei) [9]. This
may suggest that the pleiotropic e¡ect was a consequence of
morphological alterations of the lens. However, Nop lenses
studied during embryonic development revealed as the ¢rst
alteration, preceding morphological changes, a reduced level
of (Q)-crystallin mRNA [31]. Studies on early stages of normal
and mutant lenses on the basis of highly resolved 2D protein
patterns might allow us to follow the single steps of patho-
genesis leading to cataract phenotypes. For this purpose, how-
ever, more proteins need to be identi¢ed in 2D patterns of the
eye lens.
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